Prime Minister Datuk Seri Anwar Ibrahim today held high-level meetings with business leaders from six multinational companies ...

In England, about 600 people will benefit from the daily pill that helps treat lung cancer as it becomes routinely available on the NHS.

The MRHA, which overseas the safety of medicines, vaccines and healthcare devices, was accused of not acting fast enough when ...

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £155.58. The ...

Trinasolar, a global leader in smart PV and energy storage, has partnered with Smart Commercial Solar to deliver an advanced ...

Analysts predict sales of Dato-DXd could hit $5.9 billion in 2030, but the antibody-drug conjugate faced a series of setbacks ...

Pharmaceutical giant AstraZeneca has transformed an underused space at its Sydney headquarters into a renewable energy asset ...

Daily pill on NHS offers new hope for hundreds with lung cancer - Osimertinib, also known as Tagrisso and made by AstraZeneca ...

DelveInsight's“Bullous Pemphigoid Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bullous Pemphigoid, historical and forecasted epidemiology as ...

Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...

AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), ...